152 related articles for article (PubMed ID: 38432677)
21. Cross-Sectional Imaging of Intrahepatic Cholangiocarcinoma: Development, Growth, Spread, and Prognosis.
Seo N; Kim DY; Choi JY
AJR Am J Roentgenol; 2017 Aug; 209(2):W64-W75. PubMed ID: 28570102
[TBL] [Abstract][Full Text] [Related]
22. Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-alpha and stromal-derived factor-1 released in stroma.
Ohira S; Sasaki M; Harada K; Sato Y; Zen Y; Isse K; Kozaka K; Ishikawa A; Oda K; Nimura Y; Nakanuma Y
Am J Pathol; 2006 Apr; 168(4):1155-68. PubMed ID: 16565491
[TBL] [Abstract][Full Text] [Related]
23. [New advances in the diagnosis and treatment of intrahepatic cholangiocarcinoma].
Qin DL; Chen JL; Tang Y; Li ZL; Tang ZH; Quan ZW
Zhonghua Wai Ke Za Zhi; 2024 Apr; 62(4):331-337. PubMed ID: 38432675
[TBL] [Abstract][Full Text] [Related]
24. Protocol for inducing branching morphogenesis in human cholangiocyte and cholangiocarcinoma organoids.
Ober K; Roos FJM; van Tienderen GS; Köten K; Klaassen A; Mi W; van der Laan LJW; Verstegen MMA
STAR Protoc; 2023 Sep; 4(3):102431. PubMed ID: 37432852
[TBL] [Abstract][Full Text] [Related]
25. The focus clinical research in intrahepatic cholangiocarcinoma.
Song Y; Cai M; Li Y; Liu S
Eur J Med Res; 2022 Jul; 27(1):116. PubMed ID: 35820926
[TBL] [Abstract][Full Text] [Related]
26. Comparison of incidence of intrahepatic and extrahepatic cholangiocarcinoma--focus on East and South-Eastern Asia.
Shin HR; Oh JK; Masuyer E; Curado MP; Bouvard V; Fang Y; Wiangnon S; Sripa B; Hong ST
Asian Pac J Cancer Prev; 2010; 11(5):1159-66. PubMed ID: 21198257
[TBL] [Abstract][Full Text] [Related]
27. Establishment and characterization of a new intrahepatic cholangiocarcinoma cell line, ICC-X3.
Xu H; Luo W; Zhao Z; Miao X; Chai C; Hu J; Tang H; Zhang H; Zhou W
Hum Cell; 2023 Mar; 36(2):854-865. PubMed ID: 36662372
[TBL] [Abstract][Full Text] [Related]
28. Patient-derived functional organoids as a personalized approach for drug screening against hepatobiliary cancers.
Li L; Selaru FM
Adv Cancer Res; 2022; 156():319-341. PubMed ID: 35961704
[TBL] [Abstract][Full Text] [Related]
29. Intrahepatic cholangiocarcinoma: a worthy challenge.
Bartlett DL
Cancer J; 2009; 15(3):255-6. PubMed ID: 19556913
[No Abstract] [Full Text] [Related]
30. A synopsis of prostate organoid methodologies, applications, and limitations.
Gleave AM; Ci X; Lin D; Wang Y
Prostate; 2020 May; 80(6):518-526. PubMed ID: 32084293
[TBL] [Abstract][Full Text] [Related]
31. CAFs shape myeloid-derived suppressor cells to promote stemness of intrahepatic cholangiocarcinoma through 5-lipoxygenase.
Lin Y; Cai Q; Chen Y; Shi T; Liu W; Mao L; Deng B; Ying Z; Gao Y; Luo H; Yang X; Huang X; Shi Y; He R
Hepatology; 2022 Jan; 75(1):28-42. PubMed ID: 34387870
[TBL] [Abstract][Full Text] [Related]
32. The role of Tripartite motif containing 59 (TRIM59) in the proliferation and prognosis of intrahepatic cholangiocarcinoma.
Zhang JN; Ding DY; Yang SY; Tao QF; Yang Y; Zhou WP
Pathol Res Pract; 2022 Aug; 236():153989. PubMed ID: 35753134
[TBL] [Abstract][Full Text] [Related]
33. [Cholangiocarcinomas developing on multiple bile duct hamartomas syndrome].
Droy L; Sagan C; Paineau J; Gournay J; Mosnier JF
Ann Pathol; 2009 Feb; 29(1):24-7. PubMed ID: 19233090
[TBL] [Abstract][Full Text] [Related]
34. [Intrahepatic cholangiocarcinoma on a hydatidic cyst].
Molina FX; Morón JM; de la Serna S; Martí-Corbella A; Soro JA
Cir Esp; 2007 Sep; 82(3):182-4. PubMed ID: 17916292
[TBL] [Abstract][Full Text] [Related]
35. Defining the biology of intrahepatic cholangiocarcinoma: molecular pathways and early detection of precursor lesions.
Gibiino G; Fabbri C; Fagiuoli S; Ianiro G; Fornelli A; Cennamo V
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):730-741. PubMed ID: 28272710
[TBL] [Abstract][Full Text] [Related]
36. [Gallbladder and bile duct carcinoma. Biology and pathology].
Tannapfel A; Wittekind C
Internist (Berl); 2004 Jan; 45(1):33-41. PubMed ID: 14735242
[TBL] [Abstract][Full Text] [Related]
37. Update on liver transplantation for cholangiocarcinoma : a review of the recent literature.
Laurent S; Verhelst X; Geerts A; Geboes K; De Man M; Troisi R; Vanlander A; Rogiers X; Berrevoet F; Van Vlierberghe H
Acta Gastroenterol Belg; 2019; 82(3):417-420. PubMed ID: 31566330
[TBL] [Abstract][Full Text] [Related]
38. Intrahepatic cholangiocarcinoma and hepatitis: case study and literature review.
Luh F; Kuei A; Fann P; Chu P; Yen Y
Anticancer Res; 2009 Aug; 29(8):3239-43. PubMed ID: 19661341
[TBL] [Abstract][Full Text] [Related]
39. Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine.
Praharaj PP; Bhutia SK; Nagrath S; Bitting RL; Deep G
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):117-127. PubMed ID: 29360544
[TBL] [Abstract][Full Text] [Related]
40. [Pathology of cholangiocarcinoma].
Guedj N; Bedossa P; Paradis V
Ann Pathol; 2010 Dec; 30(6):455-63. PubMed ID: 21167432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
